Economics of screening for carcinoma of the prostate

S. A. Optenberg, I. M. Thompson

Research output: Contribution to journalReview article

114 Scopus citations

Abstract

The proposition of whether to adopt a system of mass screening for carcinoma of the prostate in the U.S. is well suited to the clinical decision analysis approach. The authors demonstrate this by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive. The method also permits calculation of the eventual morbidity of screening and its costs. This analysis demonstrates the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard.

Original languageEnglish (US)
Pages (from-to)719-737
Number of pages19
JournalUrologic Clinics of North America
Volume17
Issue number4
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Economics of screening for carcinoma of the prostate'. Together they form a unique fingerprint.

  • Cite this

    Optenberg, S. A., & Thompson, I. M. (1990). Economics of screening for carcinoma of the prostate. Urologic Clinics of North America, 17(4), 719-737.